A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or ...

InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, ...

Growth hormone deficiency (GHD) is a rare disorder characterized by the insufficient production of growth hormone, which is essential for stimulating the growth of bones and other tissues. Children ...

Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

The development of Generative AI (Gen AI) in clinical trials has been likened to a progressive journey from infancy to maturity. As Gen AI reaches advanced stages, it also introduces risks such as ...

In the world of biopharmaceutical innovation, groundbreaking scientific discoveries often do not directly translate into commercial success. Simply developing a promising therapeutic based on great ...

Then: In 2016, when former Life Science Leader editor Rob Wright wrote about cofounder Peter Hecht and Ironwood Pharmaceuticals, the company was ascending. After its initial launch in 1998, the ...

No drug is free from risks, and no two human anatomies are completely identical (meaning different individuals can face different risks), but from a real-world patient perspective — anecdotally — the ...